Amniotic Membrane Market Size, Share, By Product (Lyophilization and Cryopreserved), By Application (Ophthalmology, Surgical Wounds, and Others), and By End User (Hospitals, Specialized Clinics, Ambulatory Surgical Centres, and Research Centres & Laboratory), and By Region – Market Trends, Analysis and Forecast till 2034

Report Code: PMI10018 | Publish Date: April 2024 | No. of Pages: 175

Global Amniotic Membrane Market Market Companies

  • Amnio Technology, LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
  • Applied Biologics LLC
  • Amniox Medical, Inc.
  • AlloCure
  • Alliqua BioMedical, Inc.
  • FzioMed, Inc.
  • Skye Biologics, Inc.
  • IOP Ophthalmics
  • CESCA THERAPEUTICS
  • Bellicum Pharmaceuticals
  • Human Regenerative Technologies, LLC

“*” marked represents similar segmentation in other categories in the respective section.

Recent Developments:

  • On June 25, 2024, The New Launch from AxoGen (AXGN) to Support Peripheral Nerve Protection AxoGen Avive+ Soft Tissue Matrix, AXGN's newest product, is now available for full use. Avive+ is a multi-layer, resorbable amniotic membrane allograft intended to be a barrier between soft tissues. It provides protection and temporary tissue separation during the critical phase of peripheral nerve healing.
  • In April 2024, Xtant Medical is pleased to introduce SimpliGraftTM and SimpliMaxTM for acute and chronic wounds. A worldwide leader in medical technology, Xtant Medical Holdings, Inc. (NYSE American: XTNT) has announced the full commercial launch of two amniotic membrane allografts, SimpliGraftTM and SimpliMaxTM. The firm specializes in surgical treatments for spinal problems.